Cargando…
Fibrosis Distinguishes Critical Limb Ischemia Patients from Claudicants in a Transcriptomic and Histologic Analysis
Most patients with critical limb ischemia (CLI) from peripheral arterial disease (PAD) do not have antecedent intermittent claudication (IC). We hypothesized that transcriptomic analysis would identify CLI-specific pathways, particularly in regards to fibrosis. Derivation cohort data from muscle bio...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763090/ https://www.ncbi.nlm.nih.gov/pubmed/33302519 http://dx.doi.org/10.3390/jcm9123974 |
_version_ | 1783627934858215424 |
---|---|
author | Cong, Guangzhi Cui, Xiangdong Ferrari, Ricardo Pipinos, Iraklis I. Casale, George P. Chattopadhyay, Ansuman Sachdev, Ulka |
author_facet | Cong, Guangzhi Cui, Xiangdong Ferrari, Ricardo Pipinos, Iraklis I. Casale, George P. Chattopadhyay, Ansuman Sachdev, Ulka |
author_sort | Cong, Guangzhi |
collection | PubMed |
description | Most patients with critical limb ischemia (CLI) from peripheral arterial disease (PAD) do not have antecedent intermittent claudication (IC). We hypothesized that transcriptomic analysis would identify CLI-specific pathways, particularly in regards to fibrosis. Derivation cohort data from muscle biopsies in PAD and non-PAD (controls) was obtained from the Gene Expression Omnibus (GSE120642). Transcriptomic analysis indicated CLI patients (N = 16) had a unique gene expression profile, when compared with non-PAD controls (N = 15) and IC (N = 20). Ninety-eight genes differed between controls and IC, 2489 genes differed between CLI and controls, and 2783 genes differed between CLI and IC patients. Pathway enrichment analysis showed that pathways associated with TGFβ, collagen deposition, and VEGF signaling were enriched in CLI but not IC. Receiver operating curve (ROC) analysis of nine fibrosis core gene expression revealed the areas under the ROC (AUC) were all >0.75 for CLI. Furthermore, the fibrosis area (AUC = 0.81) and % fibrosis (AUC = 0.87) in validation cohort validated the fibrosis discrimination CLI from IC and control (all n = 12). In conclusion, transcriptomic analysis identified fibrosis pathways, including those involving TGFβ, as a novel gene expression feature for CLI but not IC. Fibrosis is an important characteristic of CLI, which we confirmed histologically, and may be a target for novel therapies in PAD. |
format | Online Article Text |
id | pubmed-7763090 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77630902020-12-27 Fibrosis Distinguishes Critical Limb Ischemia Patients from Claudicants in a Transcriptomic and Histologic Analysis Cong, Guangzhi Cui, Xiangdong Ferrari, Ricardo Pipinos, Iraklis I. Casale, George P. Chattopadhyay, Ansuman Sachdev, Ulka J Clin Med Article Most patients with critical limb ischemia (CLI) from peripheral arterial disease (PAD) do not have antecedent intermittent claudication (IC). We hypothesized that transcriptomic analysis would identify CLI-specific pathways, particularly in regards to fibrosis. Derivation cohort data from muscle biopsies in PAD and non-PAD (controls) was obtained from the Gene Expression Omnibus (GSE120642). Transcriptomic analysis indicated CLI patients (N = 16) had a unique gene expression profile, when compared with non-PAD controls (N = 15) and IC (N = 20). Ninety-eight genes differed between controls and IC, 2489 genes differed between CLI and controls, and 2783 genes differed between CLI and IC patients. Pathway enrichment analysis showed that pathways associated with TGFβ, collagen deposition, and VEGF signaling were enriched in CLI but not IC. Receiver operating curve (ROC) analysis of nine fibrosis core gene expression revealed the areas under the ROC (AUC) were all >0.75 for CLI. Furthermore, the fibrosis area (AUC = 0.81) and % fibrosis (AUC = 0.87) in validation cohort validated the fibrosis discrimination CLI from IC and control (all n = 12). In conclusion, transcriptomic analysis identified fibrosis pathways, including those involving TGFβ, as a novel gene expression feature for CLI but not IC. Fibrosis is an important characteristic of CLI, which we confirmed histologically, and may be a target for novel therapies in PAD. MDPI 2020-12-08 /pmc/articles/PMC7763090/ /pubmed/33302519 http://dx.doi.org/10.3390/jcm9123974 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cong, Guangzhi Cui, Xiangdong Ferrari, Ricardo Pipinos, Iraklis I. Casale, George P. Chattopadhyay, Ansuman Sachdev, Ulka Fibrosis Distinguishes Critical Limb Ischemia Patients from Claudicants in a Transcriptomic and Histologic Analysis |
title | Fibrosis Distinguishes Critical Limb Ischemia Patients from Claudicants in a Transcriptomic and Histologic Analysis |
title_full | Fibrosis Distinguishes Critical Limb Ischemia Patients from Claudicants in a Transcriptomic and Histologic Analysis |
title_fullStr | Fibrosis Distinguishes Critical Limb Ischemia Patients from Claudicants in a Transcriptomic and Histologic Analysis |
title_full_unstemmed | Fibrosis Distinguishes Critical Limb Ischemia Patients from Claudicants in a Transcriptomic and Histologic Analysis |
title_short | Fibrosis Distinguishes Critical Limb Ischemia Patients from Claudicants in a Transcriptomic and Histologic Analysis |
title_sort | fibrosis distinguishes critical limb ischemia patients from claudicants in a transcriptomic and histologic analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763090/ https://www.ncbi.nlm.nih.gov/pubmed/33302519 http://dx.doi.org/10.3390/jcm9123974 |
work_keys_str_mv | AT congguangzhi fibrosisdistinguishescriticallimbischemiapatientsfromclaudicantsinatranscriptomicandhistologicanalysis AT cuixiangdong fibrosisdistinguishescriticallimbischemiapatientsfromclaudicantsinatranscriptomicandhistologicanalysis AT ferrariricardo fibrosisdistinguishescriticallimbischemiapatientsfromclaudicantsinatranscriptomicandhistologicanalysis AT pipinosiraklisi fibrosisdistinguishescriticallimbischemiapatientsfromclaudicantsinatranscriptomicandhistologicanalysis AT casalegeorgep fibrosisdistinguishescriticallimbischemiapatientsfromclaudicantsinatranscriptomicandhistologicanalysis AT chattopadhyayansuman fibrosisdistinguishescriticallimbischemiapatientsfromclaudicantsinatranscriptomicandhistologicanalysis AT sachdevulka fibrosisdistinguishescriticallimbischemiapatientsfromclaudicantsinatranscriptomicandhistologicanalysis |